Cargando…

G-rich sequence factor 1 serves as a prognostic biomarker in septic patients

BACKGROUND: Sepsis is a condition of organ dysfunction caused by infection, and is unavoidably related to costs and mortality; however, no biomarker has yet been identified to clearly predict the prognosis of septic patients. In this study, we aimed to explore the role of guanine-rich sequence facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Lei, Wu, Yao, Li, Ming, Xu, Cheng, Mao, Guomin, Liang, Guiwen, Dong, Yansong, Yan, Dajun, Yan, Yan, Huang, Zhongwei, Sun, Kai, Jiang, Haiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106065/ https://www.ncbi.nlm.nih.gov/pubmed/33987389 http://dx.doi.org/10.21037/atm-21-1022

Ejemplares similares

The expression of STEAP4 in peripheral blood predicts the outcome of septic patients
por: Jiang, Haiyan, et al.
Publicado: (2021)

The effect of HES130/0.4 sodium chloride solution on kidney function following early fluid resuscitation in shock patients
por: Jiang, Haiyan, et al.
Publicado: (2021)

The role of lipoprotein-associated phospholipase A2 in acute kidney injury of septic mice
por: Liang, Guiwen, et al.
Publicado: (2020)

Research progress of circRNA as a biomarker of sepsis: a narrative review
por: Qi, Lei, et al.
Publicado: (2021)

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
por: Yang, Dingquan, et al.
Publicado: (2020)

SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Liu, Gaohua, et al.
Publicado: (2022)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020)

HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer
por: Wang, Feng-Jiao, et al.
Publicado: (2021)

Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2021)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2021)

microRNA-132 inhibits the proliferation, migration, and invasion of ovarian cancer cells by regulating CT10 oncogenic gene homolog II-related signaling pathways
por: Jiang, Haiyan, et al.
Publicado: (2020)

Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma
por: Aizemaiti, Rusidanmu, et al.
Publicado: (2021)

OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer
por: Mao, Min, et al.
Publicado: (2021)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
por: Li, Peng, et al.
Publicado: (2022)

Serum Circular FoxO3a Serves as a Novel Prognostic Biomarker in Squamous Cervical Cancer
por: Tang, Xiaoyan, et al.
Publicado: (2020)

Conditional transcriptional relationships may serve as cancer prognostic markers
por: Yu, Hui, et al.
Publicado: (2021)

Ancient genes can be served as pan‐cancer diagnostic and prognostic biomarkers
por: Ji, Xiangwen, et al.
Publicado: (2020)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
por: Yoo, Wonbeak, et al.
Publicado: (2023)

Prediction of 30-day mortality in heart failure patients with hypoxic hepatitis: Development and external validation of an interpretable machine learning model
por: Sun, Run, et al.
Publicado: (2022)

An AC-Rich Bean Element Serves as an Ethylene-Responsive Element in Arabidopsis
por: Wang, Chunying, et al.
Publicado: (2020)

Serum periostin level is not sufficient to serve as a clinically applicable biomarker of osteoarthritis
por: Tan, Qizhao, et al.
Publicado: (2022)

Exosomal Long Non-coding RNAs Serve as Biomarkers for Liver Disease
por: Yang, Zixuan, et al.
Publicado: (2023)

Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer
por: Xie, Yuan, et al.
Publicado: (2017)

CDK1 serves as a potential prognostic biomarker and target for lung cancer
por: Li, Mingyao, et al.
Publicado: (2020)

Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer
por: Chen, Fei, et al.
Publicado: (2021)

SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
por: Zhang, Xiuao, et al.
Publicado: (2022)

ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma
por: ling, Jie, et al.
Publicado: (2022)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
por: Hansen, Frederik J., et al.
Publicado: (2023)

Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer
por: Sun, Qiran, et al.
Publicado: (2023)

Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nt45o56gboaj4pkt5p8iekv3eb